格隆汇12月2日｜有投资者在互动平台向会通股份提问：公司和华为在那些方面有业务合作？会通股份 回复称，华为系公司客户，公司与华为在通讯、3C消费等领域保持良好稳定的合作关系。 ...

格隆汇12月2日丨会通股份(688219.SH)在投资者互动平台表示，华为系公司客户，公司与华为在通讯、 3C消费等领域保持良好稳定的合作关系。 ...

Core Viewpoint - The stock price of Huitong Co., Ltd. has shown a year-to-date increase of 15.31%, but has recently experienced declines over various trading periods, indicating potential volatility in the market [2]. Company Overview - Huitong New Materials Co., Ltd. is located in Hefei High-tech Zone, Anhui Province, and was established on July 31, 2008, with its listing date on November 18, 2020 [2]. - The company specializes in the research, production, and sales of modified plastics, with its main business revenue composition being: modified plastics 44.23%, polyolefin series 26.98%, engineering plastics and other series 10.42%, elastomers and other engineering materials 7.40%, polystyrene series 6.83%, polyamide series 3.03%, and other businesses 1.06% [2]. Financial Performance - For the period from January to September 2025, Huitong Co., Ltd. achieved an operating income of 4.721 billion yuan, representing a year-on-year growth of 10.03%, and a net profit attributable to shareholders of 166 million yuan, with a year-on-year increase of 8.96% [2]. - The company has distributed a total of 179 million yuan in dividends since its A-share listing, with 126 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders of Huitong Co., Ltd. reached 18,000, an increase of 42.39% from the previous period, with an average of 30,593 circulating shares per person, a decrease of 19.14% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the seventh largest shareholder, holding 5.3357 million shares as a new shareholder [3].

Core Viewpoint - The company, Huitong Co., has established deep collaborations with several well-known clients and brands, including BYD, Seres, Changan, SAIC Volkswagen, and FAW Volkswagen [2] Group 1 - Huitong Co. is actively engaging with major automotive brands, indicating a strong position in the industry [2] - The partnerships with these renowned clients suggest potential growth opportunities for Huitong Co. in the automotive sector [2]

证券日报网讯会通股份11月26日在互动平台回答投资者提问时表示，公司全面推进PCR全产业链生产布 局，目前已在华东、华南地区与上游PCR企业合资建立了生产基地，打通消费品回用-拆解-破碎-分选- 造粒-改性全产业链，并已在知名汽车、家电客户中实现批量应用。 ...

证券日报网讯会通股份11月26日在互动平台回答投资者提问时表示，公司计划投资建设"高温尼龙和 PEEK聚合项目"，打通PA6T、PA10T从原料合成到下游应用的全链条国产化，全面提升公司在高端尼 龙材料领域的市场地位。 ...

格隆汇11月26日丨会通股份(688219.SH)在投资者互动平台表示，公司暂无3D打印领域相关业务。 ...

Core Viewpoint - The company is actively engaged in the lithium battery materials sector, focusing on differentiated products to capture market opportunities in this growing field [2]. Group 1: Company Developments - The company has initiated a lithium battery wet separator project with a production capacity of 1.7 billion square meters, utilizing fully domestically produced equipment [2]. - The product offerings include wet base films, ceramic-coated films, and PVDF-coated films, which are applicable in power, energy storage batteries, and 3C fields [2]. - The company is continuously advancing the construction of this project, with some production lines already operational and supplying products [2].

每经AI快讯，有投资者在投资者互动平台提问：公司是否开发有3D打印材料？ 会通股份（688219.SH）11月26日在投资者互动平台表示，公司暂无3D打印领域相关业务。 （文章来源：每日经济新闻） ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]